NIH-funded insights into Alzheimer’s biology could help with early diagnosis, future clinical trials.

Study used technology to extend reach of existing infrastructure, linking people to care.

Study found low-dose rivaroxaban to be unsafe and ineffective compared to standard of care.

NIH-funded effort finds positive outcomes with strategies that engaged mostly unconscious, rather than conscious, thinking.